Vitamin D bioavailability: state of the art.

Borel P., Caillaud D., Cano N. J.
Critical reviews in food science and nutrition, 2015

Abstract

There has been renewed interest in vitamin D since numerous recent studies have suggested that besides its well-established roles in bone metabolism and immunity, vitamin D status is inversely associated with the incidence of several diseases, e.g., cancers, cardio-vascular diseases, and neurodegenerative diseases. Surprisingly, there is very little data on factors that affect absorption of this fat-soluble vitamin, although it is acknowledged that dietary vitamin D could help to fight against the subdeficient vitamin D status that is common in several populations. This review describes the state of the art concerning the fate of vitamin D in the human upper gastrointestinal tract and on the factors assumed to affect its absorption efficiency. The main conclusions are: (i) ergocalciferol (vitamin D2), the form mostly used in supplements and fortified foods, is apparently absorbed with similar efficiency to cholecalciferol (vitamin D3, the main dietary form), (ii) 25-hydroxyvitamin D (25OHD), the metabolite produced in the liver, and which can be found in foods, is better absorbed than the nonhydroxy vitamin D forms cholecalciferol and ergocalciferol, (iii) the amount of fat with which vitamin D is ingested does not seem to significantly modify the bioavailability of vitamin D3, (iv) the food matrix has apparently little effect on vitamin D bioavailability, (v) sucrose polyesters (Olestra) and tetrahydrolipstatin (orlistat) probably diminish vitamin D absorption, and (vi) there is apparently no effect of aging on vitamin D absorption efficiency. We also find that there is insufficient, or even no data on the following factors suspected of affecting vitamin D bioavailability: (i) effect of type and amount of dietary fiber, (ii) effect of vitamin D status, and (iii) effect of genetic variation in proteins involved in its intestinal absorption. In conclusion, further studies are needed to improve our knowledge of factors affecting vitamin D absorption efficiency. Clinical studies with labeled vitamin D, e.g., deuterated or (13)C, are needed to accurately and definitively assess the effect of various factors on its bioavailability.

Keywords

25-hydroxyvitamin D; Cholecalciferol; absorption; bioaccessibility; ergocalciferol; intestine

Articles similar to "Vitamin D bioavailability: state of the art."

• The properties of Cholecalciferol: Overview of general physiologic features and functions of vitamin D. (Vitamin D3 is a prohormone produced in skin through ultraviolet irradiation of 7-dehydrocholesterol...)
• The properties of Cholecalciferol: Vitamin D2 is much less effective than vitamin D3 in humans. (Vitamins D(2) and D(3) are generally considered to be equivalent in humans...)

Previous article

Alendronate plus cholecalciferol for the treatment of osteoporosis.

Next article

Overview of general physiologic features and functions of vitamin D.